COMPOSITIONS OF SARS-COV-2 VACCINES BASED ON THE RECEPTOR BINDING DOMAIN, EXPRESSED AS A DIMER, AND THE OUTER MEMBRANE VESICLE OF MENINGOCOCCAL GROUP B BACTERIA

This invention pertains to the sector of biotechnology, in particular, to the field of human health. It provides vaccine compositions that induce a neutralizing immune response against the SARS- CoV-2 virus. These compositions include a portion of the receptor binding protein of the SARS-Cov-2 virus...

Full description

Saved in:
Bibliographic Details
Main Authors CLIMENT RUIZ, Yanet, GARCÍA RIVERA, Dagmar, OJITO MAGAZ, Eduardo, SÁNCHEZ RAMÍREZ, Belinda, RAMÍREZ GONZÁLEZ, Ubel Jesús, BOGGIANO AYO, Tammy, OLIVA HERNÁNDEZ, Reynaldo, VEREZ BENCOMO, Vicente Guillermo, FERNÁNDEZ CASTILLO, Sonsire, PÉREZ NICADO, Rocmira, RODRÍGUEZ NODA, Laura Marta, CHEN, Guang Wu, VALDÉS BALBÍN, Yury, GONZÁLEZ RODRÍGUEZ, Humberto, CHOVEL CUERVO, Mario Landys
Format Patent
LanguageEnglish
Published 04.05.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention pertains to the sector of biotechnology, in particular, to the field of human health. It provides vaccine compositions that induce a neutralizing immune response against the SARS- CoV-2 virus. These compositions include a portion of the receptor binding protein of the SARS-Cov-2 virus, as an antigen, vesicles derived from proteins of the outer membrane of
Bibliography:Application Number: AU20210326938